M. Glados

Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer

Peter A. Fasching, Carsten Denkert, Mahdi Rezai, 2016, Clinical Cancer Research.

[Data on the epidemiology of Crohn disease in the city of Cologne].

M. Glados, A. Löffler, 1993, Medizinische Klinik.

24-month follow-up from the Patient's Anastrozole Compliance to Therapy (PACT) program evaluating the influence of a standardized information service on compliance in postmenopausal women with early breast cancer.

M. Blettner, R. Kreienberg, N. Harbeck, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer

A. Hinke, Marcus Schmidt, C. Jackisch, 2010, BMC Cancer.